Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 50% ± 19% | |
lung | 10 studies | 36% ± 14% | |
eye | 8 studies | 44% ± 22% | |
kidney | 5 studies | 25% ± 9% | |
heart | 5 studies | 34% ± 10% | |
intestine | 5 studies | 22% ± 8% | |
liver | 4 studies | 39% ± 19% | |
peripheral blood | 3 studies | 33% ± 7% | |
adipose | 3 studies | 43% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5724.76 | 1445 / 1445 | 100% | 79.49 | 183 / 183 |
lung | 100% | 6862.08 | 578 / 578 | 100% | 65.84 | 1155 / 1155 |
ovary | 100% | 6327.65 | 180 / 180 | 100% | 61.94 | 430 / 430 |
uterus | 100% | 6121.31 | 170 / 170 | 100% | 57.82 | 459 / 459 |
brain | 100% | 5576.43 | 2640 / 2642 | 100% | 35.30 | 705 / 705 |
breast | 100% | 6676.70 | 459 / 459 | 100% | 65.20 | 1117 / 1118 |
prostate | 100% | 8546.58 | 245 / 245 | 100% | 63.96 | 501 / 502 |
thymus | 100% | 10770.16 | 653 / 653 | 100% | 55.76 | 603 / 605 |
bladder | 100% | 5911.33 | 21 / 21 | 99% | 49.74 | 501 / 504 |
intestine | 100% | 7023.31 | 966 / 966 | 98% | 41.49 | 518 / 527 |
pancreas | 99% | 3172.13 | 326 / 328 | 99% | 39.32 | 176 / 178 |
stomach | 100% | 4256.75 | 359 / 359 | 98% | 41.87 | 281 / 286 |
kidney | 100% | 4762.91 | 89 / 89 | 98% | 43.87 | 882 / 901 |
adrenal gland | 100% | 6712.12 | 258 / 258 | 94% | 23.09 | 216 / 230 |
skin | 100% | 6985.98 | 1809 / 1809 | 90% | 28.70 | 426 / 472 |
liver | 100% | 3415.36 | 226 / 226 | 85% | 18.82 | 347 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.10 | 29 / 29 |
spleen | 100% | 6948.27 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.17 | 1 / 1 |
adipose | 100% | 6442.23 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6724.87 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3426.05 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 4606.83 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 3527.47 | 822 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 61% | 10.90 | 49 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0001835 | Biological process | blastocyst hatching |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0035264 | Biological process | multicellular organism growth |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0002021 | Biological process | response to dietary excess |
GO_0016042 | Biological process | lipid catabolic process |
GO_0060613 | Biological process | fat pad development |
GO_0090207 | Biological process | regulation of triglyceride metabolic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0050872 | Biological process | white fat cell differentiation |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TBL1XR1 |
Protein name | TBL1X/Y related 1 DC42 (HCG2039387) (TBL1XR1 protein) F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1) |
Synonyms | IRA1 hCG_2039387 TBLR1 |
Description | FUNCTION: F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation. . |
Accessions | A0A0D9SEW5 ENST00000428970.5 C9JCK0 ENST00000630796.2 A0A1B0GUU2 C9JBN1 ENST00000635794.1 ENST00000424913.5 ENST00000430069.5 A0A1B0GVH3 Q9BZK7 ENST00000427349.5 ENST00000704384.1 ENST00000626758.1 ENST00000437738.5 C9JCW4 C9J903 Q9H2I4 C9JLJ1 A0A0D9SF63 ENST00000431421.6 ENST00000631253.2 ENST00000450267.5 ENST00000637659.1 ENST00000457928.7 A0A0D9SFI2 C9IYU9 C9J3H2 ENST00000704385.1 C9J7E1 ENST00000352800.10 ENST00000704383.1 ENST00000630833.2 ENST00000413084.5 C9JEC9 A0A0D9SF25 ENST00000673974.1 ENST00000422442.6 ENST00000443315.5 ENST00000422066.6 ENST00000431674.5 C9JTW8 |